The Use of a Silver Containing Dressing (Acticoat) on Wound Complication Rates Post Elective Cesarean Section
NCT ID: NCT02288884
Last Updated: 2016-10-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2011-05-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section
NCT01528696
The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications
NCT03136159
Topical Silver for Prevention of Wound Infection After Cesarean Delivery
NCT01169064
Prospective Study on Cesarean Wound Outcomes
NCT01697748
Prophylactic Negative Wound Therapy in Laparotomy Wounds.
NCT03871023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Silver containing dressing
Subjects will have a silver containing dressing (Acticoat PostOp) applied at the time of elective cesarean section.
Acticoat PostOp
Standard dressing
Subjects will have a standard dressing (OpSite PostOp) applied at the time of elective cesarean section.
OpSite PostOp
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acticoat PostOp
OpSite PostOp
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \>35 at the pre-op visit
* consent to participate
Exclusion Criteria
* immunocompromised (HIV/AIDS, on immunosuppressive medications)
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saskatchewan Health Authority - Regina Area
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Regina General Hospital
Regina, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RQhealth
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.